Jpmorgan Chase & CO I Rhythm Technologies, Inc. Transaction History
Jpmorgan Chase & CO
- $1.14 Trillion
- Q2 2024
A detailed history of Jpmorgan Chase & CO transactions in I Rhythm Technologies, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 947,322 shares of IRTC stock, worth $77.1 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
947,322
Previous 963,262
1.65%
Holding current value
$77.1 Million
Previous $112 Million
8.74%
% of portfolio
0.01%
Previous 0.01%
Shares
13 transactions
Others Institutions Holding IRTC
# of Institutions
243Shares Held
35.3MCall Options Held
153KPut Options Held
149K-
Vanguard Group Inc Valley Forge, PA2.98MShares$243 Million0.01% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI2.69MShares$219 Million0.46% of portfolio
-
Black Rock Inc. New York, NY2.5MShares$204 Million0.01% of portfolio
-
Capital Research Global Investors Los Angeles, CA2.49MShares$203 Million0.06% of portfolio
-
Sands Capital Management, LLC Arlington, VA2.13MShares$173 Million0.7% of portfolio
About iRhythm Technologies, Inc.
- Ticker IRTC
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 30,026,600
- Market Cap $2.45B
- Description
- iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. It offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platf...